All In Biotech

Drug Trial Radar · NCT07037277

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 880 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

880

Planned (sponsor's estimate)

Start

Jun 2, 2025

Primary completion

Dec 2026

Study completion Mar 2027

Sponsor

Lead sponsor
Atea Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jun 25, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.

Conditions

  • HEPATITIS C VIRUS CHRONIC INFECTION
  • Hepatitis C, Chronic
  • Hepatitis C Virus Infection
  • Hepatitis C

Interventions

  • Bemnifosbuvir-RuzasvirDrug

    BEM/RZR Fixed-dose Combination (FDC) tablets administered orally once daily for a total of 8 weeks (in those without cirrhosis) or 12 weeks (in those with compensated cirrhosis)

  • Sofosbuvir-VelpatasvirDrug

    SOF/VEL Fixed-dose Combination (FDC) tablets administered orally once daily for a total of 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Portion of subjects achieving HCV RNA less than the lower limit of quantitation (LLOQ) at week 24Time frame: Day 1 through Week 24

Locations

107 sites in 17 countries. Site status is shown where the registry gives one.

  • Atea Study Site

    Cairo, Egypt

  • Atea Study Site

    Nice, Alpes Maritimes, France

  • Atea Study Site

    Strasbourg, Bas Rhin, France

  • Atea Study Site

    Clichy, Hauts De Seine, France

  • Atea Study Site

    Montpellier, Herault, France

  • Atea Study Site

    Clermont-Ferrand, Puy De Dome, France

  • Atea Study Site

    Créteil, Val De Marne, France

  • Atea Study Site

    Hamburg, Germany

  • Atea Study Site

    Frankfurt am Main, Hesse, Germany

  • Atea Study Site

    Leipzig, Saxony, Germany

  • Atea Study Site

    Alexandroupoli, Greece

  • Atea Study Site

    Athens, Greece

  • Atea Study Site

    Athens, Greece

  • Atea Study Site

    Heraklion, Greece

  • Atea Study Site

    Rhodes, Greece

  • Atea Study Site

    Hyderabad, Andhra Pradesh, India

  • Atea Study Site

    Patna, Bihar, India

  • Atea Study Site

    Rajkot, Gujarat, India

  • Atea Study Site

    Surat, Gujarat, India

  • Atea Study Site

    Shimla, Himachal Pradesh, India

  • Atea Study Site

    Belagavi, Karnataka, India

  • Atea Study Site

    Kochi, Kerala, India

  • Atea Study Site

    Mumbai, Maharashtra, India

  • Atea Study Site

    Mumbai, Maharashtra, India

  • Atea Study Site

    Nagpur, Maharashtra, India

  • Atea Study Site

    Pune, Maharashtra, India

  • Atea Study Site

    Pune, Maharashtra, India

  • Atea Study Site

    Chandigarh, Punjab, India

  • Atea Study Site

    Ludhiana, Punjab, India

  • Atea Study Site

    Agra, Uttar Pradesh, India

  • Atea Study Site

    Kanpur, Uttar Pradesh, India

  • Atea Study Site

    Lucknow, Uttar Pradesh, India

  • Atea Study Site

    Varanasi, Uttar Pradesh, India

  • Atea Study Site

    Kolkata, West Bengal, India

  • Atea Study Site

    Kuala Lumpur, Malaysia

  • Atea Study Site

    Kota Bharu, Kelantan, Malaysia

  • Atea Study Site

    Kota Bharu, Kelantan, Malaysia

  • Atea Study Site

    Ampang, Kuala Lumpur, Malaysia

  • Atea Study Site

    Kuantan, Pahang, Malaysia

  • Atea Study Site

    Kota Kinabalu, Sabah, Malaysia

Showing 40 of 107 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.